homocysteine has been researched along with Hyperlipemia in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.74) | 18.7374 |
1990's | 23 (20.00) | 18.2507 |
2000's | 72 (62.61) | 29.6817 |
2010's | 15 (13.04) | 24.3611 |
2020's | 3 (2.61) | 2.80 |
Authors | Studies |
---|---|
Almer, G; Brunner, MS; Bubalo, V; Cvirn, G; Diwoky, C; Frank, S; Groselj-Strele, A; Herrmann, M; Hoefler, G; Holzapfel, GA; Hörl, G; Kolb, D; Kratky, D; Lechleitner, M; Leitinger, G; Mangge, H; Marsche, G; Niedrist, T; Opriessnig, P; Oswald, W; Paar, M; Rechberger, GN; Schauer, S; Schoiswohl, G; Schwarz, AN; Sommer, G; Tehlivets, O; Wolinski, H | 1 |
Cao, P; Chan, L; Chan, P; Chang, Z; Chao, Y; Chen, Z; Deng, B; Lyu, Q; Pan, Y; Que, R; Tan, EK; Wang, Q; Wang, T; Wang, Y; Xu, L; Yang, W; Yenari, MA; Yuan, F; Zhu, S | 1 |
Imam, MU; Ishaka, A; Ismail, M | 1 |
Chattopadhyay, S; Dash, M; De, SK; Dey, A; Jana, L; Jana, S; Maity, PP; Perveen, H | 1 |
Chen, Q; Hsu, YH; Jiang, S; Venners, SA; Wang, X; Xing, H; Xu, X; Zhong, G | 1 |
Chu, L; Dong, N; Wang, B; Xiao, L | 1 |
Cheng, Y; Hua, X; Jiang, YD; Liang, Y; Ma, CJ; Ma, SC; Tian, J; Wang, J; Yang, AN; Yang, XL | 1 |
Chen, Y; Kang, B; Li, Y; Liang, R; Liang, Y; Lv, W; Xie, J; Zhou, Y | 1 |
Reimann, M; Weiss, N; Ziemssen, T | 1 |
Reimann, M; Rüdiger, H; Weiss, N; Ziemssen, T | 1 |
Bonaterra, G; Dugi, KA; Edler, L; Hildebrandt, W; Kinscherf, R; Sauer, R | 1 |
La'ulu, SL; Pfeiffer, CM; Rawlins, ML; Roberts, WL; Zhang, M | 1 |
Choi, YM; Choue, R; Lim, HJ | 1 |
Bansal, V; Kalita, J; Kumar, G; Misra, UK | 1 |
Huang, L; Li, Y; Song, XM; Zhu, WL | 1 |
Collins, P; Cooney, MT; Daly, C; Fitzgerald, AP; Graham, IM; O'Callaghan, P | 1 |
Carru, C; Hare, DL; Jin, X; Lau, E; Learmont, J; Schwartz, GD; Sutarga, K; Wijaya, BP; Wookey, PJ; Zinellu, A; Zulli, A | 1 |
Seymen, HO; Seymen, P; Titiz, MI; Türkmen, MF; Yildiz, M | 1 |
Chatzopoulos, S; Hatzitolios, A; Mikhailidis, D; Ntaios, G; Savopoulos, C | 1 |
Ahn, YK; Baek, SH; Byun, YS; Cho, KI; Choi, DJ; Choi, SW; Choi, YS; Jang, Y; Jeon, DW; Kim, JY; Kim, KS; Kim, YJ; Lee, SH; Min, PK; Rha, SW | 1 |
Hayes, KC; Khosla, P | 1 |
Bian, H; Chang, XX; Gao, X; Xia, MF; Xu, Q; Yan, HM; Zhu, TF | 1 |
Kurban, S; Mehmetoglu, I; Polat, H; Yerlikaya, FH | 1 |
Gong, H; Jiang, Y; Shi, Y; Sun, T; Sun, W; Wang, J; Wei, J; Yang, B; Zhang, H | 1 |
Bornstein, S; Julius, U; Müller, G; Rodionov, RN; Tselmin, S | 1 |
Connelly, PW; Cunnane, SC; Faulkner, D; Jackson, CJ; Jenkins, DJ; Josse, RG; Kendall, CW; Leiter, LA; Parker, T; Vidgen, E | 1 |
Acosta, AM; Cisternas, M; Gutiérrez, MA; Jacobelli, S; Klaassen, J | 1 |
Connelly, PW; Faulkner, D; Haight, JS; Jenkins, DJ; Kendall, CW; Lapsley, KG; Marchie, A; Parker, TL; Qian, W; Spiller, GA; Vidgen, E | 1 |
Elisaf, M | 1 |
McLaughlin, MA; Nguyen, VH | 1 |
Baumann, G; Stangl, K; Stangl, V | 1 |
Bushnell, CD; Goldstein, LB | 1 |
Narkiewicz, M; Rutkowski, B; Wasilewska, A; Łysiak-Szydłowska, W | 1 |
Stone, NJ | 1 |
Biciková, M; Dvoráková, K; Hill, M; Stárka, L; Tallová, J; Vrbíková, J | 1 |
Prichard, S | 1 |
Boysen, G; Brander, T; Christensen, H; Gideon, R; Truelsen, T | 1 |
Griffin, BP; Novaro, GM | 1 |
Ceska, R; Grauova, B; Haas, T; Hradec, J; Kozich, V; Krijt, J; Malik, J; Melenovsky, V; Stulc, T; Wichterle, D | 1 |
Chasiotis, G; Elisaf, MS; Kakafika, A; Milionis, HJ; Papakostas, J; Seferiadis, K | 1 |
Bharadwaj, RP; Dwivedi, RN; Gupta, OK; Narain, VS; Puri, A; Singh, S | 1 |
Connelly, PW; Faulkner, D; Jenkins, DJ; Josse, RG; Kendall, CW; Lapsley, KG; Leiter, LA; Marchie, A; Parker, TL; Trautwein, EA; Vidgen, E | 1 |
Dierkes, J; Luley, C; Westphal, S | 1 |
Choy, PC; Mymin, D; O, K; Siow, YL | 1 |
Bottiglieri, T; Caso, V; Conte, C; Corea, F; Floridi, A; Lanari, A; Parnetti, L; Santucci, A | 1 |
Al-Waili, NS | 1 |
Baró, L; Boza, JJ; Carrero, JJ; Castillo, R; Fonollá, J; González-Santiago, M; Jiménez, J; López-Huertas, E; Martínez-Férez, A | 1 |
Aikawa, M; Kobayashi, H; Kobori, Y; Matsuoka, O; Shindo, N; Takazawa, K; Tanaka, N; Teramoto, T; Yamashina, A | 1 |
Herer, P; Luboshitzky, R | 1 |
Afrasyap, L; Oztürk, G | 1 |
Dobordzhginidze, LM | 1 |
Bozic, M; Fressart, MM; Keber, I; Sebestjen, M; Simcic, S; Stegnar, M; Zegura, B | 1 |
Racek, J; Rusnáková, H; Siala, KK; Trefil, L | 1 |
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR | 1 |
Assmann, G; Cullen, P; Schulte, H | 1 |
Písaríková, A; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M | 2 |
Nubé, MJ; Nurmohamed, SA | 1 |
Torre-Villalvazo, I; Torres, N; Tovar, AR | 1 |
Erzen, B; Keber, I; Poredos, P; Sabovic, M; Sebestjen, M; Simcic, S; Zegura, B | 1 |
Bauer, K; Fischer, P; Huber, K; Jungwirth, S; Tragl, KH; Zehetmayer, S | 1 |
Kneteman, N; Lilly, L; Marotta, P; Peltekian, K; Roy, A; Scudamore, C; Tchervenkov, J | 1 |
Arai, H | 1 |
Bozzini, C; Corrocher, R; Faccini, G; Friso, S; Girelli, D; Guarini, P; Martinelli, N; Olivieri, O; Pizzolo, F; Trabetti, E | 1 |
Cattaneo, M; Faioni, EM; Fontana, G; Lombardi, R; Lussana, F; Maioli, C; Moroni, G; Podda, GM; Ponticelli, C | 1 |
Archetti, S; Borroni, B; Cesana, BM; Ferrari, M; Padovani, A | 1 |
Li, D; Wang, LJ; Wang, Q; Xie, HB; Yu, P; Yu, XM; Zhang, YH; Zhou, XQ | 2 |
Barros, N; Cardien, LC; D'Almeida, V; Ferreira, SR; Garofolo, L; Miranda, F | 1 |
Arai, H; Egashira, T; Hattori, H; Horibe, H; Ishikawa, Y; Itakura, H; Kita, T; Mabuchi, H; Matsuzawa, Y; Nakaya, N; Oikawa, S; Ouchi, Y; Saito, Y; Sasaki, J; Teramoto, T; Yamada, N; Yamamoto, A | 1 |
Glueck, CJ; Lang, JE; Shaw, P; Sieve-Smith, L; Tracy, T; Wang, Y | 1 |
Superko, HR | 1 |
Penny, WJ | 1 |
Le, NA | 1 |
Blom, HJ; Kluijtmans, LA; Kok, FJ; Kruyssen, DA; Refsum, H; Ueland, PM; Verhoef, P | 1 |
Chook, P; Sanderson, JE; Woo, KS; Young, RP | 1 |
Tonstad, S | 1 |
Abbate, R; Brunelli, T; Capanni, M; Fatini, C; Gensini, GF; Marcucci, R; Pepe, G; Prisco, D; Sardi, I; Simonetti, I | 1 |
Wanner, C; Zimmermann, J | 1 |
de Lorgeril, M; Lacan, P; Paillard, F; Richard, G; Salen, P | 1 |
Arnesen, H; Brude, IR; Drevon, CA; Finstad, HS; Hjermann, I; Nenseter, MS; Sandstad, B; Seljeflot, I; Solvoll, K | 1 |
McNamara, JR; Schaefer, EJ; Seman, LJ | 1 |
Aarsland, T; Grundt, H; Hetland, O; Mansoor, MA; Nilsen, DW; Woie, L | 1 |
Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL | 1 |
Titus, K | 1 |
Clagett, GP; Jackson, MR; McIntyre, KE; Modrall, JG; Valentine, RJ | 1 |
Bruckert, E; Foglietti, MJ; Giral, P; Jacob, N; Turpin, G | 1 |
Chait, A; Clark, S; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Snyder, GW; Stern, JS | 1 |
Chan, JC; Chan, N | 1 |
Ciuffetti, G; Locati, EH; Lombardini, R; Lupattelli, G; Mannarino, E; Rufini, S; Siepi, D | 1 |
Chait, A; Clark, S; Eastgard, RL; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; Malinow, MR; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Nevin, DN; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Reusser, ME; Snyder, GW; Stern, JS | 1 |
Abramowicz, D; Broeders, N; Knoop, C | 1 |
Ashley, J; St Jeor, S; Winston, M | 1 |
Hughes, S | 1 |
Bloomgarden, ZT | 1 |
Hamada, C; Kitaoka, M; Kurihara, H; Kuwaki, T; Morita, H; Nagai, R; Suzuki, S; Yazaki, Y | 1 |
McCarty, MF | 1 |
Garber, AJ | 1 |
Al-Ahmad, A; Konstam, MA; Salem, DN; Sarnak, MJ | 1 |
Brown, WV | 1 |
Abletshauser, C; Goedicke, C; Haak, E; Haak, T; Hermanns, N; Kusterer, K; Lackner, K; Martin, N; Usadel, KH; Weber, S | 1 |
Pinn, G | 1 |
Doolman, R; Gavendo, S; Harats, D; Marko, D; Sela, BA; Shaish, A; Yodfat, O | 1 |
Banditt, P; Dierkes, J; Kunstmann, S; Lössner, A; Luley, C; Westphal, S | 1 |
Ceska, R; Grauová, B; Kozich, V; Melenovský, V; Stulc, T | 1 |
Gao, W; Jiang, N; Meng, Z; Tang, J | 1 |
Frohlich, JJ; Godin, DV; Green, TJ; Hill, J; McManus, BM; Moghadasian, MH; Nadji, M; Nguyen, LB; Scudamore, CH; Shefer, S; Yang, Y | 1 |
Bostom, AG | 1 |
Hiatt, WR; Regensteiner, JG | 1 |
Goodson, N | 1 |
Knopp, RH | 1 |
Asnani, S; Desouza, C; Fonseca, V; Homan, J; McNamara, DB; Murthy, SN | 1 |
McCully, KS | 1 |
Mitsumata, M; Nishida, K; Tomikawa, M; Yamane, T; Yoshida, Y | 1 |
28 review(s) available for homocysteine and Hyperlipemia
Article | Year |
---|---|
Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Clinical Trials as Topic; Fibric Acids; Homocysteine; Humans; Hydrochlorothiazide; Hyperhomocysteinemia; Hyperlipidemias; Hypoglycemia; Iatrogenic Disease; Metabolic Syndrome; Metformin; Middle Aged | 2011 |
Effects of fibrates on serum metabolic parameters.
Topics: Anticholesteremic Agents; Carbohydrates; Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney; Lipoproteins; Liver; Triglycerides; Uric Acid | 2002 |
Coronary artery disease in women: a review of emerging cardiovascular risk factors.
Topics: Anticholesteremic Agents; Biomarkers; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Oxidative Stress; Risk Factors; Thrombophilia; Women's Health | 2002 |
Coronary atherogenic risk factors in women.
Topics: Blood Coagulation Factors; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Complications; Exercise; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoprotein(a); Menopause; Obesity; Pedigree; Risk Factors; Smoking; Stress, Psychological; Triglycerides | 2002 |
Risk factors for coronary artery disease in patients with renal failure.
Topics: Calcium; Coronary Artery Disease; Diabetes Mellitus; Homocysteine; Humans; Hyperlipidemias; Hypertension; Inflammation; Nitric Oxide; Oxidants; Phosphates; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Calcific aortic stenosis: another face of atherosclerosis?
Topics: Aortic Valve Stenosis; Calcinosis; Disease Progression; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Risk Factors | 2003 |
The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels.
Topics: Fenofibrate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Niacin; Risk Factors; Simvastatin | 2004 |
Lipids and atherosclerosis.
Topics: Arteriosclerosis; Chemokines; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Lipoproteins, LDL; Risk Factors | 2004 |
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fenofibrate; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Triglycerides | 2004 |
Reverse epidemiology: paradoxical observations in haemodialysis patients.
Topics: Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Glycation End Products, Advanced; Homocysteine; Humans; Hyperlipidemias; Hypertension, Renal; Hypotension; Kidney Failure, Chronic; Risk Factors | 2005 |
Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.
Topics: Adipocytes; Bile Acids and Salts; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Glucagon; Homeostasis; Homocysteine; Humans; Hyperlipidemias; Insulin; Intestinal Absorption; Kidney Diseases; Lipid Metabolism; Liver; Liver Diseases; Obesity; Soybean Proteins; Sterol Regulatory Element Binding Protein 1 | 2006 |
[Importance of vascular aspects in Alzheimer's disease].
Topics: Accidental Falls; Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cause of Death; Cerebral Infarction; Diabetes Complications; Homocysteine; Humans; Hyperlipidemias; Hypertension; Life Style; Pneumonia, Aspiration; Risk Factors | 2006 |
Lipid disorders contributing to coronary heart disease: an update.
Topics: Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Risk | 1996 |
Hyperlipidemia and cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias | 1997 |
New risk factors for coronary heart disease in Asia.
Topics: Adult; Aged; Aging; Asia; Child; Cholesterol, HDL; Coronary Disease; Endothelium, Vascular; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Middle Aged; Obesity; Risk Factors; Smoking | 1997 |
Causes of coronary heart disease in patients on renal replacement therapy.
Topics: Animals; Apolipoproteins B; Coronary Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Risk Factors | 1998 |
Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors.
Topics: Biomarkers; Coronary Disease; Diet; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Risk Factors; Triglycerides | 1999 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Diet controversies in lipid therapy.
Topics: Antioxidants; Diet; Dietary Fats; Homocysteine; Humans; Hyperlipidemias; Nursing Research; Phytotherapy | 2000 |
Novel risk factors for coronary heart disease: emerging connections.
Topics: Arteriosclerosis; Coronary Disease; Hemostasis; Homocysteine; Humans; Hyperlipidemias; Inflammation; Iron; Lipoproteins; Risk Factors | 2000 |
Attenuating cardiovascular risk factors in patients with type 2 diabetes.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Patient Education as Topic; Risk Factors; Smoking Cessation; Teaching Materials | 2000 |
Cause and management of heart failure in patients with chronic renal disease.
Topics: Diabetes Complications; Heart Failure; Homocysteine; Humans; Hyperlipidemias; Hypertension; Kidney Failure, Chronic; Renal Dialysis; Risk Factors; Uremia | 2001 |
Risk factors for vascular disease in patients with diabetes.
Topics: Diabetic Angiopathies; Homocysteine; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Insulin Resistance; Models, Cardiovascular; Obesity; Risk Factors; Smoking; Thrombophilia | 2000 |
Current medical therapies for patients with peripheral arterial disease: a critical review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Diabetes Mellitus; Estrogens; Exercise; Homocysteine; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Meta-Analysis as Topic; Myocardial Ischemia; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tetrazoles | 2002 |
Coronary artery disease and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Comorbidity; Coronary Artery Disease; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Hypertension; Risk Factors; Smoking; Survival Analysis; Survival Rate | 2002 |
Risk factors for coronary artery disease in women.
Topics: C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Metabolic Syndrome; Risk Factors | 2002 |
Hormones and homocysteine.
Topics: Diabetic Angiopathies; Homocysteine; Hormones; Humans; Hyperhomocysteinemia; Hyperlipidemias; Methionine; Vascular Diseases | 2002 |
Homocystine, atherosclerosis and thrombosis: implications for oral contraceptive users.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Arteriosclerosis; Child; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Embolism; Female; Glucose; Homocysteine; Homocystine; Homocystinuria; Humans; Hydro-Lyases; Hyperlipidemias; Methionine; Thrombosis | 1975 |
28 trial(s) available for homocysteine and Hyperlipemia
Article | Year |
---|---|
Different responses of the retinal and cutaneous microcirculation to transient dysmetabolic conditions.
Topics: Acetylcholine; Administration, Cutaneous; Adult; Dietary Fats; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Iontophoresis; Laser-Doppler Flowmetry; Light; Male; Methionine; Microcirculation; Microvessels; Photic Stimulation; Predictive Value of Tests; Regional Blood Flow; Reproducibility of Results; Retinal Vessels; Skin; Vasodilation; Vasodilator Agents; Young Adult | 2015 |
Acute hyperlipidemia but not hyperhomocysteinemia impairs reflex regulation of the cardiovascular system.
Topics: Adrenergic beta-Agonists; Adult; Baroreflex; Blood Pressure; Cardiovascular System; Dietary Fats; Germany; Heart Rate; Hemodynamics; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methionine; Sympathetic Nervous System; Time Factors; Vagus Nerve; Vasodilator Agents; Young Adult | 2015 |
Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status.
Topics: Acetylcysteine; Administration, Oral; Adult; Antihypertensive Agents; Antioxidants; Biotransformation; Cholesterol; Cysteine; Double-Blind Method; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Leukocytes, Mononuclear; Male; Middle Aged; Smoking; Triglycerides | 2015 |
Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Chi-Square Distribution; Diet; Diet Records; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Korea; Lipids; Male; Middle Aged; Vitamins | 2008 |
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Topics: Aged; Asian People; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Creatinine; Drug Combinations; Enzymes; Female; Fenofibrate; Fluorobenzenes; Hemoglobins; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Patient Selection; Pyrimidines; Republic of Korea; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.
Topics: Blood Pressure; Cholesterol; Coronary Disease; Cross-Over Studies; Dietary Proteins; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Hyperlipidemias; Isoflavones; Lipids; Male; Middle Aged; Postmenopause; Soybean Proteins | 2002 |
Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.
Topics: Aged; Coronary Disease; Cross-Over Studies; Dietary Supplements; Eating; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lung; Male; Middle Aged; Nitric Oxide; Nuts; Prunus; Risk Factors | 2002 |
Homocysteine testing in patients with acute ischemic stroke.
Topics: Acute Disease; Age Factors; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus; Embolism; Female; Homocysteine; Humans; Hyperlipidemias; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Stroke | 2002 |
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.
Topics: Cholesterol; Creatinine; Cysteine; Female; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Statistics as Topic; Triglycerides; Uric Acid | 2003 |
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Topics: Analysis of Variance; Atorvastatin; Blood Glucose; Female; Fenofibrate; Heptanoic Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Simvastatin; Uric Acid | 2003 |
The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Cholesterol, Dietary; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Erythrocyte Deformability; Female; Food Preferences; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Phytosterols; Prunus; Risk Factors; Satiety Response; Soybean Proteins | 2003 |
Natural honey lowers plasma glucose, C-reactive protein, homocysteine, and blood lipids in healthy, diabetic, and hyperlipidemic subjects: comparison with dextrose and sucrose.
Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glucose; Homocysteine; Honey; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Middle Aged; Sucrose | 2004 |
Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
Topics: Aged; Animals; Antioxidants; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Malondialdehyde; Middle Aged; Milk; Oleic Acid; Risk Factors; Spain; Time Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin B Complex; Vitamin E | 2004 |
Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
Topics: Adult; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Disease; Female; Homocysteine; Humans; Hyperlipidemias; Hypothyroidism; Middle Aged; Reference Values; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Sterols; Triglycerides | 2004 |
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors.
Topics: Adult; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Body Weight; C-Reactive Protein; Cholesterol, LDL; Clofibric Acid; Cytokines; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pyridines; Risk Factors | 2004 |
The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia.
Topics: Adult; Aged; Antioxidants; Biomarkers; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress | 2005 |
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome | 2005 |
N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
Topics: Adult; Albuminuria; Cholesterol Esters; Clofibric Acid; Diabetes Mellitus, Type 1; Dietary Supplements; Fatty Acids; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Phosphatidylcholines; Placebos; Stearic Acids; Triglycerides | 2006 |
[Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Inflammation Mediators; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Single-Blind Method | 2005 |
Lipid-lowering drugs and homocysteine.
Topics: Amino Acids; Coronary Disease; Double-Blind Method; Fenofibrate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Simvastatin | 1999 |
Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Diet; Double-Blind Method; Fatty Acids, Omega-3; Glutathione Peroxidase; Homocysteine; Humans; Hyperlipidemias; Leukocytes, Mononuclear; Male; Middle Aged; Risk Factors; RNA, Messenger; Smoking; Vitamins | 1999 |
Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Bleeding Time; Body Mass Index; Double-Blind Method; Fatty Acids; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Middle Aged; Patient Compliance; Phospholipids; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Thrombosis; Triglycerides | 1999 |
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diet; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Insulin; Male; Middle Aged; Nutritive Value; Patient Compliance; Risk Factors; Treatment Outcome; Weight Loss | 1999 |
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12 | 1999 |
Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia.
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Proteins; Capillaries; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Fatty Acids, Monounsaturated; Fluvastatin; Hemostasis; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Hyperlipidemias; Indoles; Laser-Doppler Flowmetry; Microcirculation; Microscopy, Video; Risk Factors; Time Factors; Triglycerides | 2001 |
Homocysteine elevation with fibrates: is it a class effect?
Topics: Adult; Bezafibrate; Clofibric Acid; Dietary Fats; Female; Fibric Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 2001 |
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.
Topics: Cross-Over Studies; Double-Blind Method; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Pyridoxine; Vitamin B 12; Vitamins | 2001 |
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.
Topics: Arteriosclerosis; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Pilot Projects; Risk Factors | 2001 |
59 other study(ies) available for homocysteine and Hyperlipemia
Article | Year |
---|---|
Deficiency of B vitamins leads to cholesterol-independent atherogenic transformation of the aorta.
Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Diet, Atherogenic; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Rabbits; Vitamin B Complex | 2022 |
Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; China; Cholesterol, LDL; Dementia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hyperlipidemias; Inflammation; Male; Middle Aged; Parkinson Disease; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Vascular Diseases | 2020 |
Nanoemulsification of Rice Bran Wax Policosanol Enhances Its Cardio-protective Effects via Modulation of Hepatic Peroxisome Proliferator-activated Receptor gamma in Hyperlipidemic Rats.
Topics: Animals; Cardiotonic Agents; Diet, High-Fat; Fatty Alcohols; Gene Expression; Homocysteine; Hyperlipidemias; Liver; Male; Myocardium; Oryza; Phytotherapy; PPAR gamma; Rats, Sprague-Dawley; RNA, Messenger; Waxes | 2020 |
Attenuation of utero-toxicity, metabolic dysfunction and inflammation by soy protein concentrate in rats exposed to fluoridated water: consequence of hyperlipidemia in parallel with hypohomocysteinemia.
Topics: Animals; Antioxidants; Body Weight; Estrogen Receptor alpha; Female; Homocysteine; Humans; Hyperlipidemias; Inflammation; Lipid Peroxidation; Ovary; Rats, Wistar; Sodium Fluoride; Soybean Proteins; Uterus | 2018 |
Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia.
Topics: Administration, Oral; Adult; Asian People; Biomarkers; Chi-Square Distribution; China; Chromatography, High Pressure Liquid; Down-Regulation; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Simvastatin; Time Factors; Treatment Outcome | 2013 |
Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population.
Topics: Acute Disease; Aged; Asian People; Cardiovascular Diseases; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Retinal Vein Occlusion; Risk Factors; Vitamin B 12 | 2013 |
Homocysteine induces blood vessel global hypomethylation mediated by LOX-1.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Vessels; DNA Methylation; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Mice; Scavenger Receptors, Class E | 2014 |
[Association of C677T gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine level with hyperlipidemia].
Topics: Adult; Gene Frequency; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length | 2014 |
Performance characteristics of six homocysteine assays.
Topics: Autoanalysis; Chromatography, High Pressure Liquid; Clinical Chemistry Tests; Female; Hemolysis; Homocysteine; Humans; Hyperlipidemias; Immunoassay; Jaundice; Male; Reproducibility of Results; Uncertainty | 2008 |
Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
Topics: Adult; Aged; Brain Ischemia; Comorbidity; Diabetes Mellitus; Diet, Vegetarian; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; India; Male; Middle Aged; Obesity; Risk Factors; Severity of Illness Index; Smoking; Stroke; Tomography, X-Ray Computed; Vitamin B 12 | 2009 |
Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Asian People; Base Sequence; Case-Control Studies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors | 2008 |
Homocysteine increases the risk associated with hyperlipidaemia.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Europe; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Pilot Projects; Risk Assessment; Risk Factors; Triglycerides; Up-Regulation | 2009 |
High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia.
Topics: Analysis of Variance; Animals; Apoptosis; CCAAT-Binding Factor; Coronary Artery Disease; Diet, Atherogenic; Dietary Supplements; Disease Models, Animal; Endothelium, Vascular; Homocysteine; Hyperlipidemias; Male; Methionine; Nitric Oxide; Oxidative Stress; Probability; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Taurine | 2009 |
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Female; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Lipoproteins, HDL; Male; Patient Selection; Postoperative Complications; Tacrolimus; Treatment Outcome; Triglycerides; Young Adult | 2009 |
Saturated fat and lipemia: importance of study design and triglyceride structure.
Topics: Cholesterol; Diet; Dietary Fats; Fatty Acids; Fatty Acids, Unsaturated; Female; Homocysteine; Humans; Hyperlipidemias; Inflammation Mediators; Lipid Metabolism; Male; Oleic Acid; Palmitic Acid; Plant Oils; Triglycerides | 2012 |
The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.
Topics: Animals; Aorta; Apolipoproteins; Atherosclerosis; Berberine; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Drug Evaluation, Preclinical; Homocysteine; Hydroxymethylglutaryl CoA Reductases; Hyperhomocysteinemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Rats; Rats, Sprague-Dawley; Receptors, Lipoprotein; Risk Factors | 2012 |
Plasma ω-3 fatty acid levels negatively and ω-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects.
Topics: Adult; Algorithms; Body Mass Index; Cardiovascular Diseases; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Middle Aged; Obesity; Risk Factors; Severity of Illness Index; Turkey; Vitamin B 12 Deficiency; Young Adult | 2012 |
The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cholesterol; Cholesterol, Dietary; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Gene Expression; Homocysteine; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Male; Methionine; Mice; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine; Triglycerides | 2012 |
Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Female; Germany; Homocysteine; Hospitals, University; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Triglycerides; Vitamin B Complex | 2013 |
Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chile; Cohort Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors | 2002 |
Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Cardiac Surgical Procedures; Case-Control Studies; Cholesterol; Female; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2003 |
Hyperlipidemia and cardiovascular disease.
Topics: Cardiovascular Diseases; Cholesterol; Environment; Homocysteine; Humans; Hyperlipidemias; Male | 2003 |
Plasma thiols and androgen levels in polycystic ovary syndrome.
Topics: Adolescent; Adult; Age Factors; Androgens; Androstenedione; Case-Control Studies; Cholesterol; Cholesterol, HDL; Dehydroepiandrosterone Sulfate; Estradiol; Female; Glutathione; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Regression Analysis; Sex Hormone-Binding Globulin; Sulfhydryl Compounds; Testosterone | 2003 |
Homocysteine and risk of recurrent stroke.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Denmark; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Prospective Studies; Recurrence; Risk; Risk Factors; Smoking; Stroke | 2003 |
Homocysteine and lipid levels in young patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Female; Homocysteine; Humans; Hyperlipidemias; India; Lipids; Male; Risk Factors | 2003 |
Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
Topics: Aged; Chromatography, High Pressure Liquid; Diabetes Complications; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Risk Factors; Smoking; Stroke | 2004 |
[Influence of serum homocysteine level on coronary atherosclerosis in Japanese].
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Multivariate Analysis; Radiography; Risk Factors; Severity of Illness Index; Smoking | 2004 |
Ratios of homocysteine and nitrite to high-density lipoprotein in coronary artery patients with the different degree of stenosis.
Topics: Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Evaluation Studies as Topic; Homocysteine; Humans; Hypercholesterolemia; Hyperlipidemias; Middle Aged; Nitrites; Statistics as Topic; Turkey | 2004 |
[Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Myocardial Infarction; Polymorphism, Single Nucleotide; Risk Assessment | 2005 |
Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history of myocardial infarction.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Myocardial Infarction; Risk Factors; Statistics, Nonparametric; Ultrasonography | 2007 |
Relation between vascular risk factors and cognition at age 75.
Topics: Aged; Aging; Alzheimer Disease; Austria; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cognition Disorders; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoproteins; Male; Neuropsychological Tests; Risk Factors; Smoking; Statistics as Topic; Triglycerides | 2006 |
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant.
Topics: Adult; Aged; Female; Graft Rejection; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipids; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Transplantation, Homologous | 2006 |
Homocysteine, traditional risk factors and impaired renal function in coronary artery disease.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Polymorphism, Genetic; Risk Factors; Vitamin B Complex | 2006 |
Abnormalities of homocysteine and B vitamins in the nephrotic syndrome.
Topics: Adult; Antibodies, Antiphospholipid; Antithrombins; Factor V; Female; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Nephrotic Syndrome; Risk; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Relationship of vascular risk to the progression of Alzheimer disease.
Topics: Alzheimer Disease; Apolipoproteins E; Cerebral Arteries; Cerebrovascular Disorders; Cholesterol; Disease Progression; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperlipidemias; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2007 |
[Relations of platelet phospholipid fatty acids to thrombotic risk factors in middle-aged and geriatric patients with hyperlipidemia].
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arachidonic Acid; Blood Platelets; Cholesterol; Dietary Fats; Fatty Acids; Female; Homocysteine; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Multivariate Analysis; Phospholipids; Risk Factors; Surveys and Questionnaires; Thrombosis; Thromboxane B2 | 2007 |
Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients.
Topics: Aged; Blood Platelets; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Hyperlipidemias; Male; Middle Aged; Phospholipids; Statistics as Topic | 2007 |
Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population.
Topics: Age Distribution; Aged; Asian People; Biomarkers; Body Mass Index; Brazil; Cholesterol; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Complications; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Japan; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Population Surveillance; Prevalence; Retrospective Studies; Risk Factors; Sex Distribution; Triglycerides | 2007 |
Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population.
Topics: Apolipoproteins E; Asian People; Data Collection; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Japan; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Sex Distribution | 2007 |
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.
Topics: Aged; Analysis of Variance; Arteriosclerosis; Coronary Disease; Cystathionine; Folic Acid; Homocysteine; Humans; Hyperlipidemias; Methylmalonic Acid; Middle Aged; Pyridoxine; Risk Factors | 1995 |
Hyperlipidaemia and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias | 1996 |
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Comorbidity; Coronary Artery Disease; Disease Susceptibility; Erythrocytes; Fasting; Female; Folic Acid; Genes; Genotype; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Smoking | 1997 |
Correlates of plasma total homocysteine in patients with hyperlipidaemia.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Regression Analysis; Sex Factors; Vitamin B 12 | 1997 |
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Disease; Diabetes Mellitus; Disease Susceptibility; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Hot Temperature; Humans; Hyperlipidemias; Hypertension; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Prevalence; Protein Denaturation; Recurrence; Risk Factors; Smoking | 1998 |
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
Topics: Adult; Aged; Amino Acid Substitution; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Comorbidity; Diet; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Obesity; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Pyridoxine; Risk Factors; Smoking; Tunica Intima; Ultrasonography; Vitamin B 12; Western Australia | 1999 |
The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service.
Topics: Adult; Age Factors; Age of Onset; Amputation, Surgical; Arterial Occlusive Diseases; Blood Coagulation Disorders; Blood Pressure; Confidence Intervals; Diabetes Complications; Disease Progression; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Hypertension; Incidence; Ischemia; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Peripheral Vascular Diseases; Postoperative Complications; Prevalence; Prospective Studies; Reoperation; Smoking; Treatment Outcome | 1999 |
Cysteine is a cardiovascular risk factor in hyperlipidemic patients.
Topics: Adult; Age Distribution; Aged; Arteriosclerosis; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Comorbidity; Confidence Intervals; Confounding Factors, Epidemiologic; Cysteine; Female; Homocysteine; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Assessment; Risk Factors; Sex Distribution | 1999 |
Implication of fibrate therapy for homocysteine.
Topics: Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents | 1999 |
Hyperhomocyst(e)inemia is associated with carotid atherosclerosis.
Topics: Age Factors; Body Mass Index; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Chromatography, High Pressure Liquid; Creatinine; Diabetes Complications; Female; Fluorescence; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Logistic Models; Male; Middle Aged; Regression Analysis; Risk Factors; Sex Factors; Smoking; Tunica Intima; Tunica Media; Ultrasonography; Vitamin B 12 | 1999 |
Drug treatment of lipid disorders.
Topics: Clofibric Acid; Creatinine; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Urea | 1999 |
American Diabetes Association annual meeting, 1999: dyslipidemia, endothelial dysfunction, and glycosylation.
Topics: Diabetes Mellitus; Endothelium, Vascular; Fatty Acids; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosylation; Homocysteine; Humans; Hyperlipidemias; Lipids; Organizations; United States | 2000 |
Homocysteine as a risk factor for restenosis after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Comorbidity; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Male; Middle Aged; Obesity; Recurrence; Risk Factors; Sensitivity and Specificity; Smoking | 2000 |
Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy.
Topics: Animals; Betaine; Homocysteine; Hyperlipidemias; Liver; Niacin; Rats; S-Adenosylmethionine | 2000 |
Herbs and metabolic/endocrine disease. From past to present.
Topics: Diabetes Mellitus; Gout; Homocysteine; Humans; Hyperlipidemias; Metabolic Diseases; Phytotherapy; Plants, Medicinal | 2001 |
Hyperhomocysteinemia and hyperlipidemia in coronary heart disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Coronary Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases; Point Mutation; Risk Factors; Vitamin B 12 | 1999 |
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans.
Topics: Animals; Antioxidants; Apolipoproteins E; Blood Glucose; Body Weight; Brain; Cholesterol; Esterification; Genotype; Glial Fibrillary Acidic Protein; Homocysteine; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Immunohistochemistry; Kidney; Lipase; Lipids; Lipoproteins, HDL; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurofilament Proteins; Receptors, LDL; Survival Analysis; Time Factors; Tissue Distribution | 2001 |
Effects of fenofibrate and gemfibrozil on plasma homocysteine.
Topics: Creatinine; Fenofibrate; Gemfibrozil; Glomerular Filtration Rate; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Reproducibility of Results | 2001 |
Bibliography. Current world literature. Nutrition and metabolism.
Topics: Alcohols; Animals; Apolipoproteins E; Arteriosclerosis; Biomarkers; Carbohydrate Metabolism; Cardiovascular Diseases; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Feeding Behavior; Fish Oils; Flavonoids; Garlic; Genes; Glycine max; Health Education; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Leptin; Life Style; Lipid Metabolism; Nutritional Physiological Phenomena; Obesity; Phenols; Polymers; Polyphenols; Probiotics | 2002 |
Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Bucladesine; Cell Division; Cells, Cultured; Collagen; Cyclic AMP; Cytological Techniques; DNA; Homocysteine; Hyperlipidemias; Microscopy, Electron; Microscopy, Phase-Contrast; Muscle, Smooth, Vascular; Rabbits | 1988 |